Attachment 2 - 60 day FRN

Federal Register / Vol. 74, No. 28 / Thursday, February 12, 2009 / Notices
impart information prior to testing, and
satisfaction with the testing process.
As part of the development of a model
questionnaire for inclusion in the
toolkit, three health care settings (a
hospital emergency department, a
private primary care practice and a
public primary care practice) will be
selected to pilot test the questionnaire.
In each health care site, 150 patients
will be asked to voluntarily complete a
brief computer assisted self interview
regarding their experience with the HIV
testing process during their health care
visit.

Collection of data will include
information on patient demographics
and current behaviors that may facilitate
HIV transmission; perceptions regarding
pressure to take the test; confidentiality
and privacy during testing; and patient
satisfaction and acceptance of opt-out
HIV testing. For persons who refused
HIV testing during their visit,
information about refusal will be
collected.
Results from the pilot will be assessed
to understand issues of feasibility of the
model questionnaire and validity of the
included items and scales. The findings
will be used to improve the

7067

questionnaire and protocols included in
the evaluation models toolkit.
CDC is requesting approval for a 1year clearance for data collection. CDC
estimates that 188 patients will be asked
to participate at each site and that 80%
will accept, resulting in approximately
450 new survey respondents across all
sites. The estimated average duration of
the survey is 20 minutes. Participation
is voluntary.
There is no cost to the respondents
other than their time.
The total estimated annual burden
hours are 150.

ESTIMATED ANNUALIZED BURDEN HOURS
Type of form

Average
number of
respondents
per annum

Average
number of
responses per
respondent

Average
burden per
response
(hours)

Clinic Patient Survey ...................................................................................................................

450

1

20/60

Dated: February 4, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–2973 Filed 2–11–09; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–09–09AS]

pwalker on PROD1PC71 with NOTICES

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam I. Daneshvar, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the

VerDate Nov<24>2008

17:03 Feb 11, 2009

Jkt 217001

proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Management Information System for
Comprehensive Cancer Control
Programs—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In 1994, the CDC, the American
Cancer Society, the National Cancer
Institute, the American College of
Surgeons, the North American
Association of Central Cancer Registries,
and other public health leaders at the
state and national levels began
promoting a comprehensive approach to
cancer control that would coordinate
and integrate cancer prevention and
control programs across specific cancer
funding boundaries. In 1998, the CDC
provided funding to Colorado,
Massachusetts, Michigan, North
Carolina, Texas, and the Northwest
Portland Area Indian Health Board as a
pilot to assist with implementation of
their existing comprehensive cancer
control plans. This pilot provided the
foundation for the National
Comprehensive Cancer Control Program
(NCCCP), which has since grown from

PO 00000

Frm 00035

Fmt 4703

Sfmt 4703

six programs to 65. Currently, all 50
states, the District of Columbia, seven
tribes/tribal organizations, and seven
territories/U.S. Pacific Island
jurisdictions receive funding to
implement cancer control plans.
Awards to individual applicants are
made for a five-year budget period. All
funded programs are required to submit
continuation applications and semiannual progress reports consistent with
federal requirements that all agencies, in
response to the Government
Performance and Results Act of 1993,
prepare performance plans and collect
program-specific performance measures.
These data items are listed in the
Funding Opportunity Announcement.
The data are collected on templates
which serve as a guide, but do not
standardize the information to be
collected. This non-standardized
approach to progress reporting results in
comprehensive cancer control program
reports that vary in content and detail.
Because the data are stored as
attachments rather than in a database,
information cannot be sorted or
aggregated electronically to produce
summary reports.
CDC’s Comprehensive Cancer Control
Branch (CCCB), which manages the
NCCCP, proposes to develop a databasedriven Management Information System
(MIS), which will achieve two
objectives. First, the MIS will provide
an organized source of information
about the activities and
accomplishments of all funded NCCCP
programs. Secondly, the MIS will
provide an efficient mechanism for
generating state, regional, and national

E:\FR\FM\12FEN1.SGM

12FEN1

7068

Federal Register / Vol. 74, No. 28 / Thursday, February 12, 2009 / Notices

level summary reports to monitor each
program’s progress in accomplishing
goals, and achieving program evaluation
and population-based outcomes.
OMB approval for the MIS will be
requested for a three-year period. Data
reported to CDC through the MIS will be
used by CDC to identify training and

Data will be collected electronically
twice per year. The burden per response
is expected to decrease after
respondents become experienced with
entering data and the amount of new
data to be entered decreases.
There are no costs to respondents
other than their time.

technical assistance needs, monitor
compliance with cooperative agreement
requirements, evaluate progress made in
achieving program-specific goals, and
obtain information needed to respond to
Congressional and other inquiries
regarding program activities and
effectiveness.

ESTIMATED ANNUALIZED BURDEN HOURS
Respondents

Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

NCCCP grantees .............................................................................................

65

2

6

780

Dated: February 4, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–2974 Filed 2–11–09; 8:45 am]
BILLING CODE 4163–18–P

Dated: February 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–2940 Filed 2–11–09; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

BILLING CODE 4140–01–P

Eunice Kennedy Shriver National
Institute of Child Health and Human
Development

pwalker on PROD1PC71 with NOTICES

Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group, Reproduction, Andrology,
and Gynecology Subcommittee.
Date: March 9, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Dennis Leszczynski, PhD,
Scientific Review Administrator, Division Of
Scientific Review, National Institute Of Child
Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892, (301) 435–2717,
[email protected].

VerDate Nov<24>2008

17:03 Feb 11, 2009

Jkt 217001

(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

Contact Person: Rita Anand, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd Room 5B01, Bethesda, MD
20892, (301) 496–1487,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–2942 Filed 2–11–09; 8:45 am]
BILLING CODE 4140–01–P

Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

National Institutes of Health

Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group, Pediatrics Subcommittee.
Date: March 19–20, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Legacy Hotel, 1775 Rockville
Pike, Rockville, MD 20852.

Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: March 26–27, 2009.
Time: March 26, 2009, 8:30 a.m. to 4 p.m.
Agenda: (1) Approval of Minutes and
Welcome; (2) Office of Advocacy Relations
Update; (3) Advocates in Research Working
Group Update and Discussion; (4) PCP
Update and Discussion; (5) Approaches to

PO 00000

Frm 00036

Fmt 4703

Sfmt 4703

National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.

E:\FR\FM\12FEN1.SGM

12FEN1